AFG
RVMD icon

Atomi Financial Group’s Revolution Medicines RVMD Stock Holding History

Atomi Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522K Buy
2,787
+474
+20% +$69.2K 0.01% 747
2026
Q1 		$225K Buy
+2,313
New +$234K 0.01% 1101

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Atomi Financial Group's RVMD Position: Q2 2026 in Review

Atomi Financial Group increased its Revolution Medicines (RVMD) stake by 20% in Q2 2026, buying an estimated $69.2K and bringing the position to 2,787 shares worth $522K. The position accounts for 0.01% of the portfolio, ranked #747.

Atomi Financial Group first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Atomi Financial Group held 2,787 shares of Revolution Medicines worth $522K as of Q2 2026.
  • Atomi Financial Group bought 474 Revolution Medicines shares in Q2 2026, an estimated $69.2K.
  • Revolution Medicines made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #747 holding.
  • Atomi Financial Group first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.